Correlation Between Incyte and Amicus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Incyte and Amicus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incyte and Amicus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incyte and Amicus Therapeutics, you can compare the effects of market volatilities on Incyte and Amicus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incyte with a short position of Amicus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incyte and Amicus Therapeutics.
Diversification Opportunities for Incyte and Amicus Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Incyte and Amicus is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and Amicus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amicus Therapeutics and Incyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incyte are associated (or correlated) with Amicus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amicus Therapeutics has no effect on the direction of Incyte i.e., Incyte and Amicus Therapeutics go up and down completely randomly.
Pair Corralation between Incyte and Amicus Therapeutics
Given the investment horizon of 90 days Incyte is expected to generate 1.4 times more return on investment than Amicus Therapeutics. However, Incyte is 1.4 times more volatile than Amicus Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Amicus Therapeutics is currently generating about -0.32 per unit of risk. If you would invest 7,412 in Incyte on September 1, 2024 and sell it today you would earn a total of 47.00 from holding Incyte or generate 0.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Incyte vs. Amicus Therapeutics
Performance |
| Timeline |
| Incyte |
| Amicus Therapeutics |
Incyte and Amicus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Incyte and Amicus Therapeutics
The main advantage of trading using opposite Incyte and Amicus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incyte position performs unexpectedly, Amicus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will offset losses from the drop in Amicus Therapeutics' long position.| Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
| Amicus Therapeutics vs. Incyte | Amicus Therapeutics vs. Denali Therapeutics | Amicus Therapeutics vs. argenx NV ADR | Amicus Therapeutics vs. Harmony Biosciences Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |